Development of an Algorithm for Determining of Genetic Risk at the Primary Healthcare Level - A New Tool for Primary

Polona Selič1, Zalika Klemenc-Ketiš1,2,3, Erika Zelko2,3

  • 1University of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.

Zdravstveno Varstvo
|September 21, 2020
PubMed

Insights

A new algorithm will assess genetic disease risk using family history data in Slovenia. This tool aims to identify individuals at higher risk for monogenic and polygenic diseases, improving preventive care.

Area of Science:

  • Genetics
  • Preventive Medicine
  • Public Health

Background:

  • Family history (FH) is crucial for preventive care but limited to 1-2 generations and specific diseases.
  • Current FH inquiries in Slovenia often exclude diseases with probable genetic causes.
  • No application-based algorithms exist in Slovenia for assessing chronic disease risk based on FH.

Purpose of the Study:

  • To develop a web application-based algorithm for determining risk levels of monogenic and polygenic diseases.
  • To enhance risk assessment beyond traditional family history by incorporating a broader range of genetic factors.
  • To provide a public health tool for identifying individuals at increased risk of genetic diseases.

Main Methods:

  • Developing a web application algorithm for risk assessment.
  • Collecting data from approximately 1,000 healthy individuals attending preventive examinations at 40 model family medicine practices (MFMP).
  • Gathering demographic data, three-generational FH, medical history of risk factors, and other clinical data.

Main Results:

  • The algorithm's results will be validated using clinical genetic approaches, including family pedigrees and next-generation sequencing.
  • Risk assessment for genetic diseases in the Slovenian population will be determined.
  • Clinical pathways will be developed based on the assessed risk levels.

Conclusions:

  • The study expects to contribute to the effective identification of individuals at increased risk for selected genetic diseases.
  • The public health tool will aid in assessing family predisposition to genetic conditions.
  • This initiative aims to reduce the public health burden associated with genetic diseases.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.7K
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.8K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
14.0K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
702
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
294
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.1K